Most Epilepsy Patients Benefit From Current Medications, But Look Forward to New Treatments

According to a story from Scimex, a recent assessment of available treatments for Dravet syndrome and other types of epilepsy has reaffirmed that anticonvulsant medications are still the most effective…

Continue Reading Most Epilepsy Patients Benefit From Current Medications, But Look Forward to New Treatments
ICYMI: Experimental Drug for Spinal Muscular Atrophy Gets Orphan Drug Designation
source: pixabay.com

ICYMI: Experimental Drug for Spinal Muscular Atrophy Gets Orphan Drug Designation

According to a story from BioSpace, the pharmaceutical company Scholar Rock recently announced that its drug candidate SRK-015 was recently granted Orphan Drug Designation by the U.S. FDA. The drug…

Continue Reading ICYMI: Experimental Drug for Spinal Muscular Atrophy Gets Orphan Drug Designation
A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?
source: pixabay.com

A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?

According to a story from bioportfolio.com, a recent study has demonstrated the effectiveness of Trelegy Ellipta, a unique three component combination treatment, in reducing the effects of chronic obstructive pulmonary…

Continue Reading A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?
Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
source: pixabay.com

Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage

According to a story from the Peterborough Telegraph, James Willis received a disaster diagnosis on his first Valentine's Day after getting married at age 29. James had been worried about…

Continue Reading Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
source: pixabay.com

A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy

According to a story from statnews.com, a drug derived from substances originating in the cannabis plant may be nearing approval by the U.S. Food and Drug Administration. The drug is…

Continue Reading A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy